BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20597005)

  • 1. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
    Matamouros S; England P; Dupuy B
    Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
    Dupuy B; Govind R; Antunes A; Matamouros S
    J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the pathogenicity locus in Clostridium difficile strains.
    Cohen SH; Tang YJ; Silva J
    J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus.
    Monot M; Eckert C; Lemire A; Hamiot A; Dubois T; Tessier C; Dumoulard B; Hamel B; Petit A; Lalande V; Ma L; Bouchier C; Barbut F; Dupuy B
    Sci Rep; 2015 Oct; 5():15023. PubMed ID: 26446480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
    Bakker D; Smits WK; Kuijper EJ; Corver J
    PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
    Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
    J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile.
    Elliott B; Reed R; Chang BJ; Riley TV
    Anaerobe; 2009 Dec; 15(6):249-51. PubMed ID: 19723585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of Clostridium difficile toxin gene expression by CodY.
    Dineen SS; Villapakkam AC; Nordman JT; Sonenshein AL
    Mol Microbiol; 2007 Oct; 66(1):206-19. PubMed ID: 17725558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
    Rupnik M
    FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile toxinotyping.
    Rupnik M
    Methods Mol Biol; 2010; 646():67-76. PubMed ID: 20597003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
    Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
    Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phage infection on toxin production by Clostridium difficile.
    Goh S; Chang BJ; Riley TV
    J Med Microbiol; 2005 Feb; 54(Pt 2):129-135. PubMed ID: 15673505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain.
    Ackermann G; Tang YJ; Henderson JP; Rodloff AC; Silva J; Cohen SH
    Mol Cell Probes; 2001 Oct; 15(5):301-6. PubMed ID: 11735302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
    Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
    PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.